Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,543 | 9,915 | 7,906 | 12,549 | 8,925 |
| Marketable Securities | 245 | 5,390 | 11,027 | 11,271 | 2,695 |
| Receivables | 840 | 1,018 | 1,328 | 827 | 944 |
| Inventories | 5,309 | 5,020 | 4,618 | 4,209 | 4,049 |
| TOTAL | $15,683 | $21,657 | $25,360 | $29,494 | $17,358 |
| Non-Current Assets | |||||
| PPE Net | 1,882 | 2,001 | 2,109 | 2,221 | 2,296 |
| Other Non-Current Assets | 30 | 27 | 27 | 27 | 31 |
| TOTAL | $1,912 | $2,028 | $2,136 | $2,248 | $2,327 |
| Total Assets | $17,595 | $23,685 | $27,495 | $31,742 | $19,685 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17 | N/A | 16 | 16 | 16 |
| Accounts payable and accrued liabilities | 3,904 | 2,565 | 2,777 | 3,317 | 2,469 |
| Accrued Expenses | 2,225 | 2,385 | 1,825 | 1,605 | 1,662 |
| Other current liabilities | N/A | 17 | N/A | N/A | N/A |
| TOTAL | $12,958 | $11,223 | $9,208 | $5,083 | $4,291 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,861 | 12,322 | 13,818 | 18,079 | 14,413 |
| Deferred Revenues | 145 | 145 | 145 | 145 | 145 |
| Other Non-Current Liabilities | 1,881 | 1,908 | 1,896 | 1,903 | 1,553 |
| TOTAL | $15,395 | $16,920 | $18,440 | $22,743 | $18,763 |
| Total Liabilities | $28,353 | $28,142 | $27,648 | $27,826 | $23,054 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,887 | 12,887 | 12,887 | 12,887 | 12,887 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -113,472 | -106,935 | -102,376 | -98,045 | -92,032 |
| TOTAL | $-10,758 | $-4,457 | $-152 | $3,916 | $-3,369 |
| Total Liabilities And Equity | $17,595 | $23,685 | $27,495 | $31,742 | $19,685 |